Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome (Q33271849)

25 July 2017

Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome (English)

1 reference

ORCID Public Data File 2021

25 July 2017

chronic fatigue syndrome

1 reference

1 reference

author name string

Chapenko S

1

1 reference

25 July 2017

Krumina A

2

1 reference

25 July 2017

Kozireva S

3

1 reference

25 July 2017

Nora Z

4

1 reference

25 July 2017

Sultanova A

5

1 reference

25 July 2017

Viksna L

6

1 reference

25 July 2017

Murovska M

7

1 reference

25 July 2017

1 December 2006

1 reference

Journal of Clinical Virology

25 July 2017

1 reference

25 July 2017

37 Suppl 1

1 reference

25 July 2017

S47-51

1 reference

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Quantitative analysis of human herpesvirus 6 cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Human herpesvirus 6: molecular biology and clinical features.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

A Comprehensive Immunological Analysis in Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Characteristics and Acquisition of Human Herpesvirus (HHV)–7 Infections in Relation to Infection with HHV‐6

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Sub-typing CFS patients on the basis of 'minor' symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

In vitro activation of human herpesviruses 6 and 7 from latency

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Down-regulation of human leukocyte antigen class I and II and beta 2-microglobulin expression in human herpesvirus-7-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Latent infection of human herpesvirus 7 in CD4(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970011-7

7 January 2021

10.1016/S1386-6532(06)70011-7

Identifiers

DOI

1 reference

25 July 2017

1 reference